Inflammatory responses to ischemia and reperfusion in skeletal muscle

Molecular and Cellular Biochemistry

Volumn 179, Issue 1-2, 1998, Pages 169-187

  Gute, Dean C ^a   Ishida, Tetsuya ^a   Yarimizu, Koji ^a   Korthuis, Ronald J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; Endothelium; Inflammation; Ischemia; Leukocytes; Oxygen derived free radicals; Skeletal muscle

Indexed keywords

CATALASE; CD11 ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; DIMETHYL SULFOXIDE; HYDROLASE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; OXIDIZING AGENT; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL TISSUE; BIOAVAILABILITY; CELL DAMAGE; CELL TRANSFER; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; MICROVASCULATURE; MUSCLE ISCHEMIA; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION; REPERFUSION INJURY; REVIEW; SKELETAL MUSCLE; VENULE;

CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; INFLAMMATION; ISCHEMIA; LEUKOCYTES; MICROCIRCULATION; MUSCLE, SKELETAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

ANIMALIA;

EID: 0031885708     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006832207864     Document Type: Review

References (186)

1. Garden DL, Korthuis RJ: Mechanisms of postischemic vascular dysfunction in skeletal muscle: Implications for therapeutic intervention. Microcirc Endoth Lymphatics 5: 277-298, 1989
2. Gute DC, Korthuis RJ: Role of leukocyte adherence in reperfusioninduced microvascular dysfunction and tissue injury. In: DN Granger, GW Schmid-Schonbein (eds). Physiology and Pathophysiology of Leukocyte Adhesion. Oxford University Press, Oxford, 1994
3. Korthuis RJ, Granger DN: Cellular dysfunction induced by ischemia/reperfusion: role of reactive oxygen metabolises and granulocytes. In: L Spatz , AD Bloom (eds). Biological Consequences of Oxidative Stress: Implications for Cardiovascular Disease and Carcinogenesis. Oxford University Press, New York, 1992, pp 50-77
4. Lindsay T, Romaschin A, Walker PM: Free radical mediated damage in skeletal muscle. Microcirc Endothelial Lymph 5: 157-170, 1989
5. Korthuis RJ, Anderson DC, Granger DN: Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 9: 47-71, 1994
6. Dahlback LO, Rais O: Morphological changes in striated muscle following ischemia: Immediate postischemic phase. Acta Chir Scand 131 : 430-440, 1966
7. Korthuis RJ, Garden DL, Kvietys PR, Fuseler J: Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J Appl Physiol 71: 1261-1269, 1991
8. Koller A, Kaley G: Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Cire Res 67: 529-534, 1990
9. Korthuis RJ, Granger DN, Townsley Ml, Taylor AK: The role of oxygen-derived free radicals in ischemia-induced increases in canine skeletal muscle vascular permeability. Circ Res 57: 599-609, 1985
10. Korthuis RJ, Smith JK, Carden DL: Hypoxic reperfusion attenuates postischemic microvascular injury. Am J Physiol 256: H315-H319, 1989
11. Hearse DJ, Humphrey RM, Chain EB: Abrupt reoxygenation of the anoxic potassium arrested rat heart: A study of myocardial enzyme release. J Mol Cell Cardiol 5: 395-407, 1973
12. Wright JG, Fox D, Kerr JC, Valeri CR, Hobson RW: Rate of reperfusion blood flow modulates reperfusion injury in skeletal muscle. J Surg Res 44: 754-761, 1988
13. Parks DA, Granger DN: Xanthine oxidase: Biochemistry, distribution, and physiology. Acta Physiol Scand (Suppl) 548: 87-99, 1986
14. Smith JK, Carden DL, Korthuis RJ: Role of xanthine oxidase in postischemic microvascular injury in skeletal muscle. Am J Physiol 257: H1782-H1789, 1989
15. Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 81 : 22-29, 1981
16. Granger DN, McCord JM, Parks DA, Hollwarth ME: Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology 90: 80-84, 1986
17. McKelvey TG, Hollwarth ME, Granger DN: Mechanisms of conversion from xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am J Physiol 254: G753-G760, 1988
18. Parks DA, Williams TK, Beckman JS: Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: A reevaluation. Am J Physiol 254: G768-G774, 1988
19. Batelli MG: Enzymatic conversion of rat liver xanthine oxidase from dehydrogenase (D form) to oxidase (O form). FEBS Lett 113 : 47-51, 1980
20. McCord JM: Free radicals and myocardial ischemia: Overview and outlook. Free Radical Biol Med 4: 9-14, 1988
21. Saugstad OD: Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatric Res 23: 143-150, 1988
22. Gidlof A, Hammersen F, Larsson J, Lewis DH, Liljedahl SO: Is capillary endothelium in human skeletal muscle an ischemic shock tissue. In: DH Lewis (ed). Induced Skeletal Muscle Ischemia in Man. Karger, Basel, 1982, pp 63-79
23. Larsson J, Gidlof A, Lewis DH: Effect of induced ischemia on plasma hypoxanthine levels in man. In: DH Lewis (ed). Induced Skeletal Muscle Ischemia in Man. Karger, Basel, 1982, pp 49-54
24. McCord JM: Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985
25. Lindsay T, Liauw TS, Romaschin AD: The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production is skeletal muscle. J Vasc Surg 12: 8-15, 1990
26. Della Corte E, Stirpe F: The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from the dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J 126: 739-745, 1972
27. Waud WR, Rajogopalan KV: Purification and properties of the NADdependent (type D) and O2-dependent forms of rat liver xanthine dehydrogenase. Arch Biochem Biophys 172: 354-364, 1988
28. Parks DA, Granger DN, Bulkley GB: Soybean trypsin inhibitor attenuates ischemic injury to the feline small intestine. Gastroenterology 89: 6-12, 1985
29. Smith JK, Carden DL, Grisham MB, Granger DN, Korthuis, RJ: Role of iron in postischemic microvascular injury. Am J Physiol 256: H1472-H1477, 1989
30. Ibrahim B, Stoward PJ: The histochemical localization of xanthine oxidase. J Histochem 10: 615-617, 1978
31. Jarasch ED, Grund C, Bruder G: Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium. Cell 25: 67-82, 1981
32. Jarasch ED, Bruder G, Heid HW: Significance of xanthine oxidase in capillary endothelial cells. Acta Physiol Scand (Suppl) 548: 39-46, 1986
33. Zweier JL, Kuppusamy P, Lutty GA: Measurement of endothelial cell free radical generation: Evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 85: 4046-4050, 1988
34. Grisham MB, Hernandez LA, Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251 : G567-G574, 1988
35. Bishop CT, Mirza Z, Freeman BA: Free radical damage to cultured porcine aortic endothelial cells and lung fibroblasts: Modulation by culture conditions. In vitro Cell Dev Biol 21: 229-233, 1988
36. McCutchan HJ, Schwappach JR, Enquist EG, Walden DL, Terada LS, Reiss OK, Leff JA, Repine JE: Xanthine oxidase-derived H2O2 contributes to reperfusion injury of ischemic skeletal muscle. Am J Physiol 258: H1415-H1419, 1990
37. Brown JM, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, Harden AH, Repine JE: Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest: 1297-1301, 1988
38. Terada LS, Dormish JJ, Shanley PF, Leff JA, Anderson BO, Repine JE: Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 263: L394-L401, 1992
39. Grisham MB, Granger DN: Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia and reperfusion. Clin Chest Med 10: 71-81, 1989
40. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320: 365-376, 1989
41. Winterbourne CC: Myeloperoxidase as an effective inhibitor of hydroxyl radical production. Implications of the oxidative reaction of neutrophils. J Clin Invest 78: 545-550, 1986
42. Granger DN, Hollwarth ME, Parks DA: Ischemia-reperfusion injury: Role of oxygen-derived free radicals. Acta Physiol Scand 548: 47-63, 1986
43. Fantini GA, Minei JP, Perry MO: Reperfusion with superoxide dismutase improves cellular membrane function in postischemic skeletal muscle. Surgical Forum 38: 317-319, 1987
44. 2+ transport in ischemic and reperfused skeletal muscle. J Surg Res 42: 24-32, 1987
45. Granger DN, Parks DA: Role of oxygen radicals in the pathogenesis of intestinal ischemia. Physiologist 26: 159-164, 1983
46. Bolli R: Oxygen-derived free radicals and postischemic myocardial dysfunction ('stunned myocardium'). J Am Coll Cardiol 12: 239-249, 1988
47. Menger MD, Steiner D, Messmer K: Microvascualr ischemiareperfusion injury in striated muscle: Significance of 'no-reflow'. Am J Physiol 263: H1892-H1900, 1992
48. Menger MD, Pelikan S, Steiner D, Messmer K: Microvascular ischemia-reperfusion injury in striated muscle: Significance of 'reflow paradox'. Am J Physiol 263: H1901-H1906, 1992
49. Walker PM, Lindsay TF, Labbe R, Mickle DA, Romaschin AD: Salvage of skeletal muscle with free radical scavengers. J Vasc Surg 5: 68-75, 1987
50. Perler BA, Tohmen AG, Bulkley GB: Inhibition of the compartment syndrome by ablation of the radical-mediated reperfusion injury. Surgery 108: 40-47, 1990
51. Smith JK, Carden DL, Korthuis RJ: Role of hydroxyl radicals in ischemia/reperfusion-induced injury to skeletal muscle microvasculature. FASEB J 3: A1234, 1989
52. Bolli R, Shu W, Hartley CJ, Michael LH, Repine JE, Hess ML, Kukreja RC, Roberts R: Attenuation of dysfunction in the postischemic 'stunned' myocardium bydimethylthiourea. Circulation 76: 458-468, 1987
53. Fantini GA, Yoshioka T: Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol 264: H1953-H1959, 1993
54. Bolli R, Patel BS, Shu WX, O'Neill PG, Hartley CS, Charlat ML, Roberts R: The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction. Am J Physiol 253: H 137-H 1380, 1987
55. Hernandez LA, Grisham MB, Granger DN: A role for iron in oxidantmediated ischemic injury to intestinal microvaculature. Am J Physiol 253: G49-G53, 1987
56. Reddy BR, Kloner RA, Przklenk K: Early treatment with deferoxamine limits myocardial ischemic/reperfusiohn injury. Free Radical Biol Med 7: 45-52, 1989
57. Bolli R, Patel BS, Jeroudi MO, Li XY, Triana JF, Lai EK, McCay PB: Iron-mediated radical reactions upon reperfusion contribute to myocardial 'stunning'. Am J Physiol 259: H1901-H1911, 1990
58. Maruyama M, Pieper GM, Kalyanaraman B: Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J Cardiovasc Pharmacol 17: 166-175, 1991
59. Sinaceur J, Ribiere C, Nordmann J, Nordmann R: Desferrioxamine: A scavenger of superoxide radicals. Biochem Pharmacol 33: 1693-1694, 1984
60. Halliwell B: Use of desferrioxamine as a 'probe' for iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical. Biochem Pharmacol 34: 229-233, 1985
61. Darley-Usmar VM, Hersey A, Garland LG: A method for comparative assessment of antioxidants as peroxyl radical scavengers. Biochem Pharmacol 38: 1465-1469, 1989
62. Hartley A, Davies M, Rice-Evans C: Desferrioxamine as a chainbreaking antioxidant in sickle cell membranes. FEBS Lett 264: 145-148, 1990
63. Klebanoff SJ, Waltersdorph AM: Inhibition of peroxidase-catalyzed reactions by deferoxamine. Arch Biochem Biophys 264: 600-606, 1988
64. Grisham MB, McCord JM: Chemistry and cytotoxicity of reactive oxygen metabolites. In: AK Taylor, S Matalon, PA Ward. (eds). Physiology of Oxygen Radicals. American Physiological Society, Bethesda, 1986, pp 1-18
65. Rodell TC, Cheronis JC, Ohnemus CL, Piermattei DS, Repine JE: Xanthine oxidase mediates elastase-induced injury to isolated lungs and endothelium. J Appl Physiol 63: 2159-2163, 1987
66. Phan SH, Gannon DE, Varani J, Ryan US, Ward PA: Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol 134: 1201-1211, 1989
67. Moorhouse PC , Grootveld M, Hal l iwell B, Quinlan JG , G utteridge JM : Al lopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 213: 23-28, 1987
68. Zimmerman BJ, Parks DA, Grisham MB, Granger DN: Allopurinol does not enhance antioxidant properties of extracellular fluid. Am J Physiol 255: H202-H206, 1988
69. Carden DL, Smith JK, Korthuis RJ: Oxidant-mediated, CD18-dependent microvascular dysfunction induced by complementactivated neutrophils in skeletal muscle. Am J Physiol 260: H 1144-H1152, 1991
70. Korthuis RJ, Smith JK, Carden DL: Role of xanthine oxidase in postischemic granulocyte infiltration and microvascular injury in canine gracilis muscle. Physiologist (Suppl) 32: 158, 1989
71. Zimmerman BJ, Guillory DJ, Gaginella T, Granger DN: Role of leukoctriene B4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology 99: 1358-1363, 1990
72. Smith JK, Carden DL, Korthuis RJ: Activated neutrophils increase microvascular permeability in skeletal muscle: role of xanthine oxidase. J Appl Physiol 70: 2003-2009, 1991
73. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD: Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury in skeletal muscle. J Immunol 150: 5104-5113, 1993
74. Lehr HA, Guhimann A, Nolte D, Keppler D, Messmer K: Preservation of postischemic caplilary perfusion by selective inhibition of leukotriene biosynthesis. Transplantation Proceedings 23: 833-834, 1991
75. Granger DN: Role of xanthine oxidase and granulocytes in ischemiareperfusion injury. Am J Physiol 255: H1275, 1988
76. Granger DN, Villareal D: Mechanisms of reperfusion-induced microvascular dysfunction. J Vasc Surg 18: 104-106, 1993
77. Korthuis RJ, Jerome SN: Role of neutrophils in the pathogenesis of microvascular dysfunction in postischemic skeletal muscle. J Vasc Surg 18: 114-117, 1993
78. Korthuis RJ, Grisham MB, Granger DN: Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 254: H823-H827, 1988
79. Yokota J, Minei JP, Fantini GA, Shires GT: Role of leukocytes in reperfusion injury of skeletal muscle after partial ischemia. Am J Physiol 257: H1068-H1075, 1989
80. Rubin BB, Chang G, Liauw S, Young A, Romaschin A, Walker PM: Phospholipid peroxidation dacylation and remodeling in postischemic skeletal muscle. Am J Physiol 263: H1695-H1702, 1992
81. Walden DL, McCutchan HJ, Enquist EG, Schwappach JR, Shanley PF, Reiss OK, Terada LS, Leff JA, Repione JE: Neutrophils accumulate and contribute to skeletal muscle dysfunction after ischemiareperfusion. Am J Physiol 259: H1809-H1812, 1990
82. Gallin Jl, Goldstein IM, Snyderman R: Inflammation: Basic Principles and Clinical Correlates (2nd edn). Raven Press, New York, 1992
83. Harlan JM: Leukocyte-endothelial cell interactions. Blood 65: 513-525, 1985
84. Springer T, Anderson DC, Rosenthal A: Leukocyte Adhesion Molecules. Springer-Verlag, New York, 1989
85. Tranum-Jensen J, Janse MJ, Fiolet JWT, Krieger WJG, D'Alnoncourt CN, Durrer D: Tissue osmoiality, cell swelling, and reperfusion in acute regional myocaridal ischemia in the isolated porcine heart. Circ Res 49: 364-381, 1981
86. Kurtel H, Tso P, Granger DN: Granulocyte accumulation in postischemic intestine: role of leukocyte adhesion glycoprotein CD11/CD18. Am J Physiol 262: G878-G882, 1992
87. Paterson IS, Klausner JM, Goldman G, Welbourne R, Alexander JS, Shepro D, Hechtman HB: The endothelial cell cytoskeleton modulates extravascular polymorphonuclear leukocyte accumulations in vivo. Microvasc Res 38: 49-56, 1989
88. Tanaka M, Brooks SE, Richard VJ, FitzHarris GP, Stoler RC, Jennings RB, Arfors KE, Reimer KA: Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation 87: 526-535, 1993
89. Entman ML, Youker K, Shappell SB, Seigel C, Rothlein R, Dreyer WJ, Schmalstieg FC, Smith CW: Neutrophil adherence to isolated adult canine myocytes: Evidence for a CD18-dependent mechanism. J Clin Invest 85: 1497-1506, 1990
90. Nathan CF: Neutrophil activation on biological surfaces: Massive secretion of hydrogen peroxide in response to products of macrophages and Iymphocytes. J Clin Invest 80: 1550-1560, 1987
91. Nathan CF: Respiratory burst in adherent human neutrophils: triggering by colony stimulating factors CSF-GM and CSF-G. Blood 73: 301-306, 1989
92. Shappell SB, Toman C, Anderson DC: Mac-1 (CDllb/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol 90: 1335-1345, 1990
93. Suzuki M, Inauen W, Kvietys PR, Grisham MB, Meininger C, Schelling ME, Granger HJ, Granger DN: Superoxide mediates reperfusion-induced leukocyte endothelial cell interactions. Am J Physiol 257: H1740-H1745, 1989
94. Kishimoto TK: A dynamic model for neutrophil localization to inflammatory sites. J NIH Res 3: 75-77, 1991
95. McEver RP: Selectins: Novel adhesion receptors that mediate leukocyte adhesion during inflammation. Thromb Haem 65: 223-228, 1991
96. Smith CW, Kishimoto TK, Abbassi O, Hughes BJ, Rothlein R, Mcintire LV: Chemotactic factors regulate lectn adhesion molecule-1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 87: 609, 1991
97. Dore M, Hawkins HK, Entman ML, Smith CW: P-selectin mediates spontaneous leukocyte rolling in vivo. Blood 82: 1308-1316, 1993
98. Bevilacqua MP, Strengelin S, Gimbrone MA, Seed B: Endothelialleukocyte adhesion molecule-1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243: 1160-1165, 1989
99. Bevilacqua MP, Corless C, Lo SK: Endothelial-leukocyte adhesion molecule-1 (ELAM-1): A vascular selectin that regulates inflammation. In: CG Cochrane, MG Gimbrone (eds). Cellular and Molecular Mechanisms of Inflammation (vol 2). Academic Press, San Diego, 1991, pp 1-14
100. Nolte D, Hecht R, Botzlar A, Menger MD, Sinowatz F, Messmer K, Vestweber D: Role of adhesion proteins during postischemic reperfusion of mouse striated muscle. Eur Surg Res 25: 414-415, 1993
101. Walcheck B, Moore KL, McEver RP, Kishimoto TK: Neutrophilneutrophil interactions under hydrodynamic shear stress involve Lselectin and PSGL-1. A mechanism that amplifies initial leukocyte accum ulation of P-selectin in vitro. J Clin Invest 98(5): 1081-1087, 1996
102. Guyer DA, Moore KL, Lynam EB, Schammel CM, Rogelj S, McEver RP, Sklar LA: P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for L-selectin in neutrophil aggregation. Blood 88(7): 2415-2421, 1996
103. Atherton A, Born GVR: Relationship between the velocity of rolling granulocytes and that of blood flow in venules. J Physiol 233: 157-165, 1973
104. Schmid-Schonbein GW, Shih W, Chien S: Vascular endotheliumleukocyte interaction, sticking shear force in capillaries. Circ Res 36: 173-184, 1975
105. Mayrovitz HN, Wiedeman MP, Tuma RF: Experimental and clinicalthrombosis: factors influencing leukocyte adherence in microvessels. Thromb Haem 38: 823-830, 1977
106. Carden DL, Smith JK, Korthuis RJ: Neubrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle. Circ Res 66: 1436-1444, 1990
107. Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, Entman ML: Neutrophil accumulation in ischemic myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400-411, 1991
108. Horgan MJ, Wright SD, Malik AB: Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol 259: L315-L319, 1990
109. Schoenberg MH, Poch B, Younes M, Schwartz A, Baczako K, Lundberg C, Haglund U, Berger HG: Involvement of neutrophils in postischaemic damage to the small intestine. Gut 32: 905-912, 1991
110. Oliver MG, Specian RD, Perry MA, Granger DN: Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation 15(5): 331-346, 1991
111. Suzuki M, Asako H, Kubes P, Granger DN: Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc Res 42: 125-138, 1991
112. Wesselcouch EO, Grove Rl, Demusz CD, Baird AJ: Effect of in vivo inhibition of neutrophil adherence on skeletal muscle function during ischemia in the ferret. Am J Physiol 261: H1178-H1183, 1991
113. Jerome SN, Akimitsu T, Korthuis RJ: Leukocyte adhesion, edema, and the development of postischemic capillary no-reflow. Am J Physiol 267: H 1329-H1336, 1994
114. Jerome SN, Smith CW, Korthuis RJ: CD18-dependent adherence reactions play an important role in the development of the no-reflow phenomenon. Am J Physiol 264: H479-H483, 1993
115. Horgan MJ, Ge M, Gu J, Rothlein R, Malik AB: Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol 259: L315-L319, 1991
116. Ma XL, Lefer DJ, Lefer AM, Rothlein R: Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992
117. Clark WM, Madden KP, Rothlein R, Zivin JA: Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22: 877-883, 1991
118. Smith CW, Entman ML, Lane CL, Beaudet AL, Ty TI, Youker K, Hawkins HK, Anderson DC: Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule-1. J Clin Invest 88: 1216-1223, 1991
119. Lewis RE, Granger HJ: Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4 (LTB4). Microvasc Res 35: 27-47, 1988
120. Doukas J, Shepro D, Hechtman HB: Vasoactive amines directly modify endothelial cells to affect polymorphonuclear leukocyte diapedesis in vitro. Blood 69: 1563-1569, 1987
121. Alexander JS, Hechtman HB, Shepro D: Phalloidin enhances endothelial barrier function and reduces inflam matory perm eability in vitro. Microvasc Res 35: 308-315, 1988
122. Asako H, Wolf RE, Granger DN, Korthuis RJ: Phalloidin reduces leukocyte emigration and vascular permeability in postcapil lary venules. Am J Physiol 26 : H1637-H1642, 1992
123. Lewis MS, Whatley RE, Cain P, Mcintyre TM, Prescott SM, Zimmerman GA: Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 82: 2045-2055, 1988
124. Gasic AC, McGuire G, Krater S, Farhood Al, Goldstein MA, Smith CW, Entman ML, Taylor M: Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 84: 2154-2166, 1991
125. Grisham MB: Anonymous Reactive Metabolites of Oxygen and Nitrogen in Biology and Medicine. R.G. Landes, Austin, TX. 1993
126. Zimmerman BJ, Grisham MB, Granger DN: Role of hydrogen peroxide, iron, and hydroxyl radicals in ischemia/reperfusion-induced neutrophil infiltration. Physiologist (Suppl) 31: A229, 1988
127. Zimmerman BJ, Grisham MB, Granger DN: Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am J Physiol 258: G185-G190, 1990
128. Suzuki M, Grisham MB, Granger DN: Leukocyte-endothelial cell interactions: Role of xanthine oxidase-derived oxidants. J Leukocyte Biol 50: 488-494, 1991
129. Carden DL, Korthuis RJ: Neutrophil chemotactic activity generated in canine plasma by superoxide. FASEB J 6: A2071, 1992
130. Shingu M, Nobunaga M: Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide. Am J Pathol 117: 201-206, 1984
131. Vogt W, von Zabern I, Hesse D, Nolte R, Haller Y: Generation of activated form of human C5 (C6b-like C5) by oxygen radicals. Immunol Lett 14: 209-215, 1987
132. Kubes P, Suzuki M, Granger DN: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991
133. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615, 1992
134. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson S, Miyasaka M, Granger DN: Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ Res 73: 164-171, 1993
135. Akimitsu T, Gute DC, Korthuis RJ: Leukocyte adhesion induced by inhibition of nitric oxide production in skeletal muscle. J Appl Physiol 78: 1725-1732, 1995
136. Patel KD, Zimmerman GA, Prescott SM, McEver RP, Mcintyre TM: Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 112: 749-759, 1991
137. Weiss SJ: Oxygen, ischemia, and inflammation. Acta Physiol Scand (Suppl) 548: 9-38, 1986
138. Soussi B, Idstrom JP, Schersten T, Bylund-Fellenius AC: Cytochrome c oxidase and cardiolipin alterations in response to skeletal muscle ischemia and reperfusion. Acta Physiol Scand 138: 107-114, 1991
139. Girotti AW: Mechanisms of lipid peroxidation. Free Radical Biol Med 1: 87-95, 1985
140. Perry MO, Fantini G: Ischemia: Profile of an enemy. Reperfusion injury of skeletal muscle. J Vasc Surg 6: 231-234, 1987
141. Yoshioka T, Shires GT, Fantini GA: Hypothermia relieves oxidative stress in reperfused skeletal muscle following partial ischemia. J Surg Res 53: 408-416, 1992
142. Tsai AG, Friesenecker B, Intaglietta M: Capillary flow impairment and functional capillary density. Int J Microcirc 15: 238, 1995
143. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KS, Ryan US, Ward PA: Endothelial cell killing by neutrophils. Am J Pathol 135: 435-438, 1989
144. Vissers CM, Winterbourn CC: Oxidative damage to fibronectin. The effects of the neutrophil myeloperoxidase system and HOCI. Arch Biochem Biophys 285: 53-59, 1991
145. Weiss SJ, Peppin G, Ortiz X: Oxidative auto-activation of latent collagenase by human neutrophils. Science 222: 747-749, 1985
146. Weiss SJ, Regiani S: Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinase and oxygen metabolises. J Clin Invest 73: 1297-1303, 1984
147. Carden DL, Korthuis RJ: Role of neutrophilic elastase in postischemic granulocyte extravasation and microvascular dysfunction in skeletal muscle. FASEB J 4: A1248, 1990
148. Ames A, Wright RL, Kowada M, Thurston JM, Majno GM: Cerebral ischemia: The no-reflow phenomenon. Am J Pathol 52: 437-453, 1968
149. Barroso-Aranda J, Schmid-Schonbein GW, Zweifach BW, Engler RL: Granulocytes and no-reflow in irreversible hemorrhagic shock. Circ Res 63: 437-447, 1988
150. Del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM: Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276-1283, 1991
151. Engler RL, Dahigren MD, Morris DD, Peterson MA, Schmid-Schonbein GW: Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 251: H314-H322, 1986
152. Engler RL, Dahigren MD, Morris DD, Peterson MA, Schmid-Schonbein GW: Accumulation of polymorphonuclear leukocytes during 3-h experimental myocardial ischemia. Am J Physiol 251: H93-H100, 1986
153. Engler RL, Schmid-Schonbein GW, Pavelec RS: Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 111: 98-111, 1983
154. Fischer EG, Ames A, Hedley-White ET, O'Gorman S: Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the 'no-reflow phenomenon.' Stroke 8: 36-39, 1977
155. Harmon JW: The significance of local vascular phenomena in production of ischemic necrosis in skeletal muscle. Am J Pathol 24: 625-641, 1948
156. Kloner RA, Ganote CE, Jennings RB: The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54: 1496-1508, 1974
157. Korthuis RJ, Granger DN: Ischemia-reperfusion injury: Role of oxygen-derived free radicals. In: AK Taylor, S Matalon, PA Ward PA. (eds). Physiology of Oxygen Radicals. American Physiological Society, Bethesda, MD, 1986, pp 217-250
158. Mori E, Del Zoppo GJ, Chambers D, Copeland BR, Arfors KE: Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23: 712-718, 1992
159. Schmid-Schonbein GW: Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 46: 2397-2401, 1987
160. Strock PE, Majno G: Microvascular changes in acutely ischemic rat muscle. Surg Gynecol Obstet 129(6): 1213-1224, 1969
161. Quinones-Baldrich WJ, Chervu A, Hernandez JJ, Colburn M, Moore WS: Skeletal muscle function after ischemia: 'No-reflow' versus reperfusion injury. J Surg Res 51: 5-12, 1991
162. Messina LM: In vivo assessment of acute microvascular injury after reperfusion of ischemic tibialis anterior muscle of the hamster. J Surg Res 48: 615-621, 1990
163. Bagge U, Amundson B, Lauritzen C: White blood cell deformability and plugging of skeletal muscle capillaries in hemorrhagic shock. Acta Physiol Scand 108: 159-163, 1980
164. Jerome SN, Dore M, Paulson JC, Smith CW, Korthuis RJ: P-selectin and ICAM-1 dependent adherence reactions: Role in the genesis of postischemic no-reflow. Am J Physiol 266: H1316-H1321, 1994
165. Granger DN, Benoit JN, Suzuki M, Grisham MB: Leukocyte adherence to venular endotheiium during ischemia-reperfusion. Am J Physiol 257: G683-G688, 1989
166. Hansell P, Borgstrom P, Arfors KE: Pressure-related capillary leukostasis following ischemia-reperfusion and hemorrhagic shock. Am J Physiol 265: H381-H388, 1993
167. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE: Lumenal narrowing and endothelial cell swelling in skeletal muscle capillaries during hemorrhagic shock. Circulatory Shock 29: 27-39, 1989
168. Gidlof A, Lewis DH, Hammersen F: The effect of prolonged total ischemia on the ultrastructure of human skeletal muscle capillaries. A morphometric analysis. Int J Microcirc Clin Exp 7: 67-86, 1987
169. Mazzoni MC, Borgstrom P, Intaglietta M, Arfors KE: Capillary narrowing in hemorrhagic shock is rectified by hyperosmotic salinedextran reinfusion. Circulatory Shock 31 : 407-418, 1990
170. Mazzoni MC, Intaglietta M, Cragoe EJ, Arfors KE: Amiloride-sensitive Na pathways in capillary endothelial cell swelling during hemorrhagic shock. J Appl Physiol 73: 1467-1473, 1992
171. House S, Lipowsky H: Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc Res 34: 363-379, 1987
172. Hammersen F, Barker JH, Gidlof A, Menger MD, Hammerson E, Messmer K: The ultrastructure of the microvessels and their contents following ischemia and reperfusion. Prog Appl Microcirc 13: 1 -26, 1989
173. Menger MD, Sack FU, Barker JH, Feifel G, Messmer K: Quantitative analysis of microcirculatory disorders after prolonged ischemia in skeletal muscle. Res Exp Med 188: 151-165, 1988
174. Welbourne R, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Pathophysiology of ischaemia reperfusion injury, central role of the neutrophil. Br J Surg 78: 651-655, 1991
175. Hill J, Lindsay T, Rusche J: A Mac-1 antibody reduces liver and lung injury but not neutrophil sequestration after intestinal ischem iareperfusion. Surgery 112: 166-172, 1992
176. Klausner JM, Anner H, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Lower torso ischemia-induced lung injury is leukocyte dependent. Ann Surg 209: 231-236, 1988
177. Welbourne R, Goldman G, Hill J, Kobzik L, Paterson IS, Valeri CR, Shepro D, Hechtman HB: Role of neutrophil adherence receptors (CD18) in lung permeability following lower torso ischemia. Circ Res 71: 82-86, 1992
178. Carden DL, Young JA, Granger DN: Pulmonary microvascular injury following intestinal ischemia/reperfusion: Role of P-selectin. J Appl Physiol 75: 2529-2534, 1993
179. Goldman G, Welbourne R, Klausner JM, Alexander S, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Attenuation of acid aspiration edema with phalloidin. Am J Physiol 259: L378-L383, 1990
180. Liauw K, Rubin BB, Romaschin AD, Walker PM: Sequential canine skeletal muscle ischemia: Prior ischemia/reperfusion results in contralateral muscle salvage. Am J Physiol 1996, in press
181. Mounsey RA, Pang CY, Forrest C: Preconditioning: A new technique for improved muscle flap survival. Otolaryngology-Head and Neck Surgery 107: 549-552, 1992
182. Jerome SN, Akimitsu T, Gute DC, Korthuis RJ: Ischemic preconditioning attenuates capillary no-reflow induced by prolonged ischemia and reperfusion. Am J Physiol 268: H2063-H2067, 1995
183. Akimitsu T, Gute DC, Korthuis RJ: Ischemic preconditioning (IPC) attenuates postischemic leukocyte adherence and emigration via activation of adenosine receptors during IPC and reperfusion. Microcirculation 2: 106, 1995 (Abstract)
184. Akimitsu T, Gute DC, Korthuis RJ: Ischemic preconditioning attenuates postischemic leukocyte adhesion and emigration: Role of adenosine and ATP-sensitive potassium channels. Circulation 90: 1476, 1994
185. Akimitsu T, Gute DC, Korthuis RJ: Ischemic preconditioning attenuates postischemic leukocyte adhesion and emigration. Am J Physiol 1996, in press
186. Gute DC, Akimitsu T, Korthuis RJ: Adenosine preconditioning is partially blocked by the KATP channel antagonist glibenclamide. Microcirculation 2: 1081, 1995